BridgeBio Pharma Inc. (BBIO) Tops Q3 EPS by 13c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($0.86), $0.13 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $1.56 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Trip.com Group (TCOM) Misses Q1 EPS by 41c
• Gossamer Bio Inc. (GOSS) PT Lowered to $2 at H.C. Wainwright